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As genetic testing becomes increasingly utilized in health care, consumer awareness
and understanding is critical. Both are reported to be low in Australia, though there are
limited studies to date. A consumer survey assessed perceived knowledge, awareness
and attitudes toward genetic medicine, prior to consumers’ genomics forums in
Queensland in 2018 and 2019. Data was analyzed using t-test and Mann-Whitney
U tests analysis to detect any associations between sociodemographic factors and
familiarity or attitudes. This highly educated and experienced health consumer cohort
reported they were significantly more familiar with the healthcare system generally than
genetic medicine specifically (p < 0.0001). Consumers perceived that genetic testing
would be significantly more important in the future than it is currently (p < 0.00001).
Consumers agreed that genetic testing should be promoted (91.4%), made available
(100%), better funded (94.2%), and offered to all pregnant women (81.6%). The
preferred learning modality about genetics was internet sites (62.7%) followed
by talks/presentations (30.8%). Benefits of genetic testing, reported in qualitative
responses, included the potential for additional information to promote personal
control and improve healthcare. Perceived concerns included ethical implications
(including privacy and discrimination), and current limitations of science, knowledge
and/or practice. This study demonstrates that even knowledgeable consumers have
little familiarity with genetic medicine but are optimistic about its potential benefits.
Ethical concerns, particularly concerns regarding genetic discrimination should inform
legislation and policy. Consumers are supportive of online resources in increasing
genomic literacy.
Keywords: health consumers, genetics, genomics, awareness, attitudes
INTRODUCTION
The demand and utilization of genetic and more recently genomic testing continues to increase
(Khan and Mittelman, 2018), yet all stakeholders in healthcare report low levels of awareness,
comfort and confidence. For physicians, genetic education and training is limited (Harris et al.,
2006; Harding et al., 2019). Internationally, non-genetic health professionals admit to having
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insufficient knowledge of genetics, and the role of clinical
genetics services (Houwink et al., 2011; Crellin et al., 2019;
Harding et al., 2019). Similarly, the general public report low
awareness of genetic risk factors, and knowledge regarding how
to access genetic services in healthcare (Smerecnik et al., 2008;
Hann et al., 2017).
Previous research has focused on attitudes, awareness and
knowledge of health consumers. Throughout various countries,
reported genetic literacy is low and consumers are typically
uncertain about how it applies to healthcare (Harris et al.,
2006; Smerecnik et al., 2008; Hann et al., 2017). Contrary to
reports of low genetic literacy, consumers express interest in
understanding hereditary risk and how to manage personal
genetic risk factors, but lack comprehension in genetic risk
perception, often basing it on family history and personal
experience (Henneman et al., 2003; Smerecnik et al., 2008;
Taylor, 2011). Knowledge in genetics, especially pertaining to
healthcare strongly depends upon sociodemographic factors,
where those with lower levels of education, older age, or of ethnic
minority, tend to have lower knowledge and understanding of
genetics, and are more likely to adopt a deterministic view
around genetic test results (Morren et al., 2007; Smerecnik et al.,
2008; Kaphingst et al., 2012; Rubinsak et al., 2019). Notably,
attitudes are predominantly positive toward genetic testing, and
higher levels of genetic knowledge are associated with more
positive views (Henneman et al., 2003; Morren et al., 2007;
Meisel et al., 2016).
Australia has a publicly funded health system which supports
access to genetic and genomic testing, when clinically indicated
(Australian Law Reform Commission [ALRC], 2010). Despite
its availability there are limited studies about consumer
knowledge, awareness, and attitudes toward genetic testing
in Australia. Previous studies reveal health consumers in
Australia are interested in genetic testing but fear genetic
discrimination (Molster et al., 2009). They show lower
knowledge and negative attitudes toward genetic testing are
related to lower education levels, lower household income,
and older age (Wilde et al., 2010). Lastly, they indicate
a need for more genetic education in primary healthcare
providers due to the low uptake of clinical genetic services
(Metcalfe et al., 2002).
This study involved the administration of a survey assessing
consumers’ awareness and attitudes toward genetics in healthcare
prior to a genomics educational intervention in the form of a
presentation during the health consumer forum in Queensland
in both 2018 and 2019.
MATERIALS AND METHODS
Ethics
This survey was initially administered as a marketing tool
to shape the content of future educational sessions. An
ethics application to report the findings in the literature was
approved by the University of Queensland Human Research
Ethics Committee (UQ #2019002633) with the stipulation that
quotes be paraphrased.
Participants
All delegates attending the Queensland Genomics panel
presentation on genomics in medicine, at the Health Consumer
Queensland annual forum in 2018 (Brisbane) and 2019 (Cairns)
were invited to complete the survey. Any individuals present
both years (2018 and 2019) noted this on their 2019 survey and
only their first response was included in the analysis.
Data Collection
Surveys were administered and collected prior to the genomics
education session. In 2018 the 23-item survey included: 5-
items assessing demographic information (age, gender, marital
status, education level and Aboriginal/Torres Strait Islander
identity); 5-items assessing familiarity with genetic diseases
and testing (Yes/No) (3 of which were previously validated
by Henneman et al., 2003); two items rating (scale 1–10)
their familiarity with the healthcare system generally and
genomic medicine specifically; two items rating (scale 1–10) their
perceptions regarding the importance of genetics in healthcare
currently and in the future; a rank ordered question assessing
learning modality preferences; four-items assessing attitudes
(agree/disagree) toward the availability of genetic testing; one
item assessing whether they could knew how to find a genetics
service; two open-ended fields evaluating perceived benefits and
concerns with genomic testing and one final open-ended field
for additional comments (see Table 1 for specific wording).
An additional question was added in the 2019 survey (“Did
you attend the HCQ Forum in Brisbane in 2018?”) to allow
for the removal of duplicates. See Supplementary Material for
full questionnaire.
The survey that was administered used the terms “genetic” and
“genomic” interchangeably. We use “genetic” to encompass both
terms throughout this article.
Data Analysis
All responses on 1–10 scales given as a range were converted to
averages (i.e., “3–4” was changed to “3.5”). Ranks on scales of “1–
5” which were reported as >5 were adjusted to “5.” Participants
choosing both “agree” and “disagree” were categorized as “neither
agree nor disagree.”
Descriptive statistics were performed to summarize and
describe the characteristics of the data. Student’s t-tests were
performed to test to detect any differences between means
in normally distributed data (familiarity with healthcare and
sociodemographic factors) and Mann-Whitney U tests were
used to detect differences in means in datasets which were not
normally distributed (Importance of genetics in healthcare now
and in the future, and learning preferences).
Thematic Analysis
All quotes in open-ended fields were transcribed verbatim
and analyzed thematically to identify perceived benefits and
concerns regarding genetic testing. Codes were categorized to
identify overarching themes. Codes were reconciled between two
researchers (CW and AM). Themes were reported as well as the
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TABLE 1 | Summary of consumer survey responses from 59 participants evaluating genomic familiarity, awareness, and beliefs, preferences for learning modalities, and
attitudes toward genetic testing.
Topic Questions/Items Yes, N (%)
Familiarity (Yes/No) Do you know anyone with a genetic disorder (yourself, in your family or neighborhood)? 56 (71.4)
Have you heard or read about genetic testing before attending this forum? 59 (81.4)
Did you, your partner or your children ever have a genetic test? 58 (17.2)
Have you heard of genomic medicine before attending this forum 59 (66.1)
If you needed to, would you know how to find genetic services in Queensland? 58 (40.4)
Average rating* (Range)
Beliefs How much does genetic testing affect healthcare in Queensland today? 4.97 (1–10)
How much will genetic testing affect healthcare in Queensland in the future? 7.97 (1–10)
Awareness How familiar are you with the healthcare system in Queensland? 6.64 (1–10)
How familiar are you with genomic medicine? 2.97 (1–8)
Agree (%)
Attitudes (Agree/Disagree) The use of genetic testing should be promoted? 48 (94.1)
Genetic testing should be available for those who want to use them? 52 (100)
More money should be available for the development of genetic tests? 49 (94.2)
Genetic tests should be offered to all pregnant women? 49 (81.6)
Average ranking**
Preferences for learning about genetics Internet sites 1.88
Talks and presentations 2.40
Discussions with healthcare providers 2.84
Videos 3.02
Printed materials 3.28
*On a scale of 1–10 (with 1 being the lowest). **Rank them from 1 to 5, with 1 being the most useful and 5 being the least useful. Bolding indicates significance.
frequency with which they appeared in the text. Illustrative quotes
were paraphrased to preserve consumer privacy.
RESULTS
A total of 66 individuals participated in the survey in 2018
(n = 51) and 2019 (n = 15). Seven individuals in the 2019 survey
reported having attended the Queensland Genomics presentation
for the Health Consumer Queensland annual forum in 2018, and
were therefore removed from statistical analyses, resulting in 59
unique individuals.
Demographics
The majority of participants were female [n = 41 (69.5%)], 16
were males (27.1%), and 2 were not specified (3.4%). Ages of
participants ranged from 26 to 80 years of age with the average
age being 47.3 years. This cohort was highly educated with 50
participants (84.7%) having some form of tertiary education and
28 participants (47.5%) having undertaken graduate education.
Familiarity With Genetics and Healthcare
Of the participants who completed each question, 40/56 (71.4%)
reported knowing someone with a genetic disorder personally,
11/59 (18.6%) had never heard of genetic testing before attending
the forum, and 10/58 (17.2%) reported personal experience with
genetic testing. Finally, 34/58 (59.6%) did not know how to find
genetic services in Queensland.
The average self-reported familiarity with the healthcare
system in Queensland was 6.64 (range 1–10), and the median
was 7. The average genetic medicine familiarity score was
2.97 (range 1–8) with a median of 1. T-tests found these
scores to be significantly different (refer to Table 1) (t = 8.71,
p < 0.0001). There were no correlations between these scores and
age or education.
Beliefs About Genetic Medicine
Participants perceived that genetic testing moderately affected
healthcare in Queensland today with a mean of 4.97 (range 1–
10) and median of 5 (Table 1). Participants perceived that genetic
testing would be significantly more relevant to healthcare in
Queensland in the future than it is presently with a mean of 7.97
(range 1–10) (Table 1) (z-score −4.634 p < 0.00001). There were
no correlations between these scores and age or education for
either time point.
Attitudes Toward Genetic Testing
Of the participants who provided a response, 48/51 participants
(94.1%) agreed that the use of genetic testing should be promoted
with 52/52 (100%) agreeing that genetic testing should be
available for those who want to use them, 49/52 (94.2%) agreeing
that there should be more funding and 40/49 (81.6%) agreeing
that genetic tests should be offered to all pregnant women
(Table 1). There were no demographic predictors of these ratings.
Preferences for Learning
Participants were asked to rank modalities from 1 to 5 with 1
being the highest. The preferred learning modality about genetics
was internet sites 37/59 (62.7%) followed by talks/presentations
Frontiers in Genetics | www.frontiersin.org 3 October 2020 | Volume 11 | Article 537743
fgene-11-537743 October 9, 2020 Time: 14:51 # 4
Wallingford et al. Consumer Awareness of Clinical Genetics
16/52 (30.8%). The average ranked score for each modality
was calculated (Table 1). Internet sites received an average
score of 1.88, talks and presentations 2.4, discussions with
healthcare providers 2.84, Videos 3.02 and printed materials
3.28. Mann-Whitney U-tests (Table 2) found that internet sites
were significantly preferable to all other learning modalities
including printed materials (p < 0.00001), videos (p = 0.00001),
discussions with health care providers (p = 0.001) and talks
and presentations (p = 0.019). Talks and presentations were
significantly preferable to printed material (p = 0.003) and
videos (p = 0.003) but not discussions with healthcare providers
(p = 0.265). Mann-Whitney U test found that individuals
under 45 years of age (n = 25) also preferred internet sites
above videos (p = 0.001), discussions with healthcare providers
(p = 0.032), and printed material (p = 0.00005), but there was
no differences between their preference for internet resources
as compared to talks and presentations (p = 0.172). Those
over the age 45 years (n = 29) preferred internet sites to
videos (p = 0.031), discussions with physicians (p = 0.033) and
printed materials (p = 0.028), but there were no other significant
preferences (Table 2).
Perceived Benefits of Genetics
Forty-seven written responses identified two main categories
of benefits (Table 3). More than half of the responses (28/47)
mentioned that genetic testing provided information that
promoted control and approximately one third (19/47) thought
that genetic testing could improve health care.
Forty-seven individuals provided responses describing their
concerns with genetic testing which could be broadly categorized
into two themes, namely ethical considerations (n = 32) and
knowledge limitations inhibiting interpretation and utilization
(n = 12).
DISCUSSION
Health consumers in this study were highly educated and
over two thirds personally knew an individual with a genetic
condition. Participants rated their knowledge of the healthcare
system in Queensland to be relatively high but their perceived
familiarity with genetic medicine was significantly lower. The
majority of respondents did not know how to find genetic
services in Queensland. There was overwhelming support
for integration of genetic testing into healthcare with the
majority believing it to have a greater impact in the future
than it did at present. Qualitative comments on perceived
concerns included possible ethical implications and the current
limitations of science and technology. Perceived benefits
centered on the potential for genetic information to increase
control and to improve healthcare. Internet sites and talks
or presentations were the preferred learning modalities for
genetic education.
The majority of our cohort personally knew someone with
a genetic condition. This may reflect the fact that cumulatively
rare disorders affect 6–10% of the world’s population (Zurynski
et al., 2008). However, it is likely that this represents a study
bias. This population would have an increased a priori chance
of encountering individuals with rare disorders given that they
identified as health consumers who, by definition, frequently
attend healthcare centers. Furthermore, the fact that they elected
to attend a session on genetics suggests that they had a vested
interest in the topic.
Our cohort reported moderate familiarity with the healthcare
system in Queensland, which was expected, given that they
were attending a health consumers’ forum. However, a previous
Australian study found an inverse relationship between
consumers’ perceived familiarity with healthcare systems and
experience accessing healthcare, suggesting that those who
regularly attended healthcare settings found the experience to be
more complex than they might have anticipated (Mather et al.,
2018). The apparent lack of familiarity with genetic medicine
is consistent with low knowledge of medical specialties in
Australian consumers (Gianduzzo et al., 2016) and low genetic
literacy in the general public worldwide (Smerecnik et al., 2008).
The low levels of familiarity are unexpected in this cohort,
given their health consumer roles and the fact that they are
highly educated. However, previous research has shown that
TABLE 2 | Mann-Whitney U-test analysis evaluating preferences of specific learning modalities for genetic education.
Learning modalities <45 years (N = 25) ≥45 years (N = 29) Total cohort (N = 54)
Average ranking P-value Average ranking P-value Average ranking P-value
Internet vs. Videos 1.65 vs. 3.18 0.0001 2.16 vs. 2.95 0.031 1.88 vs. 3.02 <0.00001
Internet vs. Talks/Presentations 1.65 vs. 2.23 0.172 2.16 vs. 2.45 0.105 1.88 vs. 2.40 0.019
Internet vs. Discussions with physician 1.65 vs. 2.82 0.032 2.16 vs. 2.75 0.033 1.88 vs. 2.83 0.001
Internet vs. Printed material 1.65 vs. 3.62 0.00005 2.16 vs. 3.05 0.028 1.88 vs. 3.28 0.00001
Printed material vs. Videos 3.62 vs. 3.18 0.590 3.05 vs. 2.95 0.516 3.28 vs. 3.02 0.641
Printed material vs. Talks/Presentations 3.62 vs. 2.23 0.00055 3.05 vs. 2.45 0.252 3.28 vs. 2.40 0.003
Printed material vs. Discussions with physician 3.62 vs. 2.82 0.035 3.05 vs. 2.75 0.451 3.28 vs. 2.83 0.126
Videos vs. Talks/Presentations 3.18 vs. 2.23 0.002 2.95 vs. 2.45 0.367 3.02 vs. 2.40 0.003
Videos vs. Discussions with physician 3.18 vs. 2.82 0.095 2.95 vs. 2.75 0.640 3.02 vs. 2.83 0.2083
Talks/Presentations vs. Discussions with physician 2.23 vs. 2.82 0.297 2.45 vs. 2.75 0.627 2.40 vs. 2.83 0.265
Bolding denotes significance.
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TABLE 3 | Qualitative responses in open-ended questions regarding perceived
concerns and benefits of genetic testing (n = 47).
Themes Paraphrased quotes N (%)
Concerns
Ethical implications • I am worried about my privacy being
invaded.
• Genetic discrimination and inequality.






• Genetic tests might be inaccurate.
• You might discover you have a condition for
which there is no treatment.
• Fear of uncertainty regarding the





• Information means that patients can make
informed decisions.
• Genetic testing can give you information
that allows you to consider family planning.
• Being aware of genetic risk factors means
you can make decisions about your health,
and plan for the future.
28 (59.6%)
Improve healthcare • Genetic testing might allow for more
personalized health care.
• We might develop better treatments by
increasing our understanding of conditions
using genetic testing.
• Early detection of a condition may lead to
earlier intervention.
19 (40.4%)
genetic literacy is low, even amongst well-educated populations
(Chapman et al., 2019).
The use of genetic testing in medicine will continue to rise
(Whitworth et al., 2017; Savard et al., 2019) and it is predicted
that 60 million patients will have had whole genome sequencing
by 2025 (Birney et al., 2017). It is already being mainstreamed
in specific cancer specialties e.g., breast and ovarian cancer, to
inform management decisions (Previs et al., 2016; Kentwell et al.,
2017). Our findings reflect consumer recognition and support
for these trends, with the vast majority of participants believing
that genetic testing should be funded and made accessible to
the public. This presents a challenge to the healthcare system as
it continues to manage the costs and increasing complexity of
delivery. It is therefore essential that genetic medicine is used
efficiently and in the most clinically relevant settings in order
to provide and maintain accessible and high-quality healthcare
for all health consumers. Dombrádi et al. (2019) describes
this process as a shift to value-based care, and argues that
is particularly important with genomic medicine. Participants
in this study anticipated that genetic testing would play a
significantly larger role in health care in the future than it does
currently. This aligns with previous reports that, internationally,
consumers have high expectations for the potential of genetics to
positively impact on healthcare in the future (Hall et al., 2015;
Hayeems et al., 2015; Roberts et al., 2018).
Genetic specialists are increasingly in demand, yet the supply
is relatively limited (Heald et al., 2016). With over 75,000
genetic tests available to the public (Phillips et al., 2018),
and new tests being developed regularly, consumer demand
for informational resources will increase further in the future.
Educating consumers about genetics enables them to make
informed decisions about their health, and promotes better
healthcare (Kaphingst et al., 2012). We found that the most
preferred modalities of genetic education in this cohort were
internet sites, followed by talks and presentations. These learning
preferences were largely attributable to strong preferences in
younger participants (under 45 years of age), though the
older cohort also preferred internet sites to either videos,
printed materials or discussions with healthcare providers.
This is unexpected given reports that the utilization of digital
information technologies, to obtain health information, decreases
with age (Gordon and Crouch, 2019). Online learning, and
talks or presentations are both interactive learning modalities,
shown to positively impact on consumers’ knowledge and
understanding (Alamantariotou and Zisi, 2010). E-learning
tools have been used to effectively increase knowledge and
promote informed decision making prior to genetic testing
(reviewed by Birch, 2015). Increasingly, there are calls to
develop educational resources on the topic of genetics in
healthcare (Hann et al., 2017; Krakow et al., 2018) and this
study supports this. This is the first Australian study to show
consumers’ preference for learning about genomics online, which
is consistent with a review showing that the majority of recently
developed genomic educational resources for the public are
digital (Whitley et al., 2020).
Consumers’ concerns regarding genetic testing included
possible ethical implications. Specifically, and in keeping with
previous research findings, participants expressed concern
regarding the potential for genetic discrimination (Wilde et al.,
2010), data sharing (Hann et al., 2017), breaches of privacy
(Deans et al., 2015), eugenics (Webborn et al., 2015), and
the current limitations in technology and knowledge affecting
our ability to appropriately interpret complex results (Ravitsky
et al., 2017). Concerns of genetic discrimination are particularly
warranted with regards to how genetic information is used in
determining eligibility and premium costs for certain insurance
policies in Australia (Barlow-Stewart et al., 2009; Keogh and
Otlowski, 2013; Tiller et al., 2020). This deters health consumers
from having genetic testing in both clinical and research settings,
resulting in less informed health consumers, and barriers to
medical research (Newson et al., 2017; Tiller et al., 2020).
A recent study showed that in Australasia, the majority of
genetic health professionals felt there was not enough legislation
to protect clients from genetic discrimination (Tiller et al.,
2018). It is important that the concerns of health consumers
are addressed, not only in pre-test education and counseling
sessions, but at a government policy and legislative level to ensure
the long-term protection for health consumers, and to promote
medical progress.
Perceived benefits of genetic testing included results providing
consumers with information, which could promote control over
healthcare decisions and the potential to improve healthcare.
Consistent with the literature, participants reported that genetic
testing facilitated planning and preparing for the future
(Hamilton et al., 2016; Hann et al., 2017), and the opportunity to
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engage in preventative interventions (Bloss et al., 2013; Hamilton
et al., 2016; Roberts et al., 2017). Additional benefits included
the potential for personalized medicine, and the identification
of novel treatment and cures (Dolled-Filhart et al., 2012;
Hann et al., 2017).
Limitations
Limitations of this study include a limited sample size and
a highly educated and self-selected cohort. As surveys were
administered at the Health Consumer Queensland Forum, this
sample is likely to be more highly motivated and educated
than typical healthcare consumers. Therefore, the findings are
not generalizable to all health consumer groups. Nonetheless,
the findings do provide insight into the attitudes toward and
awareness of genetics in healthcare in Queensland.
CONCLUSION
This study demonstrates that even highly educated healthcare
consumers, who are familiar with their local healthcare systems,
are significantly less familiar with clinical genetic services,
and how to access them. Consumers recognized the positive
potential of genetics and felt it would play a more significant
role in healthcare in the future than it does today. Online
educational interventions were consumers’ preferred medium for
learning about genomics.
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